This report provides top line data relating to the clinical trials on Corneal Graft Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

United Kingdom Pain Management Devices Market Report Analysis & Forecast report provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The global atopic dermatitis treatment market will more than double in value from $3.6 billion in 2014 to an estimated $7.3 billion by 2024, representing a Compound Annual Growth Rate (CAGR) of 7.5%, according to research and consulting firms. By the mid-to-late term of GlobalData's 2014 to 2024 forecast, Sanofi/Regeneron's dupilumab is expected to reshape the adult moderate and severe treatment landscape and to slowly enter the market for younger patients with milder forms of the disease.